Warnings
Medetomidine
Verwacht Bromazolam. Gedetecteerd Medetomidine. Locatie: Australia. Datum: 2025-11-27. Bron: Victorian Pill Testing Service.
Detected Substances
- Medetomidine
Expected vs Detected
Bromazolam
Detected result: Medetomidine
Sample Details
No additional sample descriptors available.
Testing Context
- Location: Australia
- Date tested: 2025-11-27
- Source: Victorian Pill Testing Service
Harm Reduction
- Similar-looking pills can contain different substances or strengths.
- Use drug checking services when available.
- Start low and avoid assuming a logo identifies the contents.
SampleDNA Beta
29 verbonden waarschuwingen · Leer meer over veelvoorkomende onzuiverheden.
- MedetomidineGedetecteerd
Gerelateerde monsters en combinaties
Medetomidine
Samen gedetecteerd in gerelateerde drug-check-resultaten.
Xanax logo
Hetzelfde logo verschijnt in gerelateerde resultaten voor drug-checks.
6-MAM + Acetylcodeine + Caffeine + Heroin + Medetomidine + Noscapine + Papaverine + Paracetamol
Samen gedetecteerd in gerelateerde drug-check-resultaten.
- Heroin + Noscapine + Paracetamol + Acetylcodeine + Caffeine + Medetomidine + 6-MAM + Papaverine
- Caffeine + Heroin + 6-MAM + Noscapine + Paracetamol + Acetylcodeine + Medetomidine + Papaverine
- Acetylcodeine + Caffeine + Heroin + 6-MAM + Noscapine + Papaverine + Paracetamol + Medetomidine
- Caffeine + Heroin + Medetomidine + 6-MAM + Noscapine + Paracetamol + Acetylcodeine + Papaverine
- Heroin + 6-MAM + Noscapine + Papaverine + Paracetamol + Acetylcodeine + Caffeine + Medetomidine
- Heroin + Medetomidine + 6-MAM + Noscapine + Paracetamol + Acetylcodeine + Caffeine + Papaverine
6-MAM + Acetylcodeine + Caffeine + Dimethocaine + Heroin + Medetomidine + Noscapine + Papaverine + Paracetamol
Samen gedetecteerd in gerelateerde drug-check-resultaten.
6-MAM + Caffeine + Dimethocaine + Heroin + Medetomidine + Noscapine + Papaverine + Paracetamol
Samen gedetecteerd in gerelateerde drug-check-resultaten.
Links
This static page is intended as the readable export baseline for crawler and low-capability delivery.
